- This event has passed.
Global Innovation for Kidney Disease
November 20, 2020 @ 10:00 am - 11:30 am
View a recording of the webinar!
This webinar is part of the series Resilience and Well-Being Through the Lens of the Pandemic, a series that examines the impact the global coronavirus pandemic has had on India and the way that the country is responding to COVID-19. The series will address key related issues in areas such as economics, medicine, urbanization and public health.
GUEST SPEAKERS
Vivekananda Jha, Executive Director, George Institute for Global Health (India); Chair of Global Kidney Health, Faculty of Medicine, Imperial College of London; President, International Society of Nephrology
Manisha Sahay, Professor and Head of Department of Nephrology, Osmania General Hospital and Osmania Medical College (Hyperabad, India)
Murray Sheldon, Associate Director for Technology and Innovation, Center for Devices and Radiological Health, U.S. Food & Drug Administration
Shuvo Roy, Professor, Department of Bioengineering and Therapeutic Sciences (BTS), University of California, San Francisco; Director of the Biodesign Laboratory and Technical Director, Kidney Project
Moderated by Prabir Roy-Chaduhury, Professor of Medicine, Division of Nephrology and Hypertension; Co-Director, UNC Kidney Center
This webinar series is hosted by the Modern Indian Studies Initiative at the University of North Carolina at Chapel Hill. As a leading public university and home to the largest Asia Studies Center in the southeastern U.S., Carolina is uniquely positioned to be at the forefront of advancing knowledge of modern India across North Carolina, the United States and beyond. In partnership with leaders from North Carolina’s Indian-American community, UNC has embarked on a bold initiative to transform the model for Indian Studies. We are forging ahead in establishing the country’s leading program in Modern Indian Studies – increasing knowledge and understanding of the India of today, and its rapidly evolving future.
about the panelists
Prabir Roy-Chaduhury
Prabir Roy-Chaduhury is a Professor of Medicine and Co-Director of the University of North Carolina Kidney Center at Chapel Hill. He has a dedicated interest in getting new kidney technologies and products to people living with kidney disease and has been involved in creating a substrate for kidney innovation nationally as the founding co-chair of the Kidney Health Initiative, a public-private partnership between the American Society of Nephrology and the US Food and Drug Administration. He is currently also a councilor for the American Society of Nephrology and a steering committee member for the Kidney X innovation accelerator.
Vivekananda Jha
Vivekananda Jha is the Executive Director at The George Institute for Global Health, India, Chair of Global Kidney Health, Faculty of Medicine, Imperial College of London, and the President of the International Society of Nephrology. Professor Jha has wide-ranging research interests, including understanding the health and societal impact of kidney diseases around the world and development of affordable, scalable and sustainable primary and secondary prevention tools. He has worked with many organizations, including the WHO to develop clinical practice guidelines and advocacy papers, has lectured extensively around the world and is a prolific writer and editor.
Manisha Sahay
Dr. Manisha Sahay is the Professor and Head, Department of Nephrology, Osmania General Hospital and Osmania Medical College, Hyderabad, India. She is a governing body member of the Indian Society of Nephrology and is closely involved with the South Asia Regional Board of the International Society of Nephrology. She has also received the “Tanker – Young Investigator Award” of the Indian Society of Nephrology.
Shuvo Roy
Shuvo Roy, PhD, is a translational bioengineer focusing on the development of medical devices to address unmet clinical needs through a multidisciplinary approach. Dr. Roy is a professor at the University of California, San Francisco in the Department of Bioengineering and Therapeutic Sciences (BTS), the director of the Biodesign Laboratory and the Technical Director of The Kidney Project. Dr. Roy was selected as a recipient of the TR100, which features the world’s 100 Top Young Innovators as selected by Technology Review. More recently, he was recognized as a Fellow by the American Institute of Medical and Biological Engineering (AIMBE) and is a recipient of the KidneyX Redesign Prize.
Murray Sheldon
Murray Sheldon is the Associate Director for Technology and Innovation at the Center for Devices and Radiological Health at the FDA. A practicing cardiothoracic surgeon for much of his career, Dr. Sheldon joined the FDA in 2013 to oversee the Center’s initiative to proactively facilitate medical device innovation to address unmet public health needs, and to align what is traditionally done at FDA with what is required to support the US medical device ecosystem. He has also been championing the development of an international consortium for kidney disease innovation.